DCTH Stock Analysis: Buy, Sell, or Hold?
DCTH - Delcath Systems Inc
$9.91
0.00 (0.00%)
▲
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 05, 2026
Get Alerted When DCTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DCTH trades at premium valuation expecting 18.7% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: DCTH trades at premium valuation expecting 18.7% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$11.00
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$6.83
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DCTH is currently trading at $9.91, which is considered oversold relative to its 30-day fair value range of $10.04 to $10.50. From a valuation perspective, the stock is trading at a premium (Forward PE: 43.9) compared to its historical average (26.2). At these levels, the market is pricing in 18.7% annual earnings growth.
Technical Outlook: Technically, DCTH is in a downtrend. The price is currently testing key support at $9.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (12th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $22.33 (+125.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DCTH is in a downtrend. The price is currently testing key support at $9.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (12th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $22.33 (+125.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$10.04 -
$10.50
Company Quality Score
49/100
(HOLD)
Options IV Signal
12th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
86.2%
Protect Your Profits
Holding DCTH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 12th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 125.4% below Wall St target ($22.33)
- BULLISH: Expecting earnings turnaround to 18.7% growth with 83.6% revenue growth
- CAUTION: Recommendation downgraded due to -5.9% 5-day decline
Fair Price Analysis
30-Day Fair Range
$10.04 -
$10.50
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.11
(11.2%)
Support & Resistance Levels
Support Level
$9.74
Resistance Level
$11.15
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
43.85
Wall Street Target
$22.33
(+125.4%)
Revenue Growth (YoY)
83.6%
Earnings Growth (YoY)
-66.7%
Profit Margin
1.5%
Valuation Premium vs History
+18.7% premium
PE vs Historical
43.9 vs 26.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+18.7%
(market-implied from PE analysis)
1-Year Target
$11.76
(+19%)
2-Year Target
$13.96
(+41%)
3-Year Target
$16.57
(+67%)
3-Yr Target (if PE normalizes)
(PE: 44→26)
PE COMPRESSION
$9.90
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 43.8, Growth: 169.0%)
$33.45
(+238%)
Base:
(SPY PE: 22.3, Growth: 169.0%)
$17.01
(+72%)
Bear:
(PE: 19.0, Growth: 169.0%)
$14.46
(+46%)
📈
Valuation based on Current Earnings
Forward PE: 15.36 | Forward EPS (Implied): $0.65
Bull Case
$11.97
(+21%)
Analyst growth 15.0%, PE expands to 16.1
Base Case
$9.91
(0%)
Market implied 0.0%, PE stable at 15.4
Bear Case
$7.58
(-24%)
Severe decline -15.0%, PE contracts to 13.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 30, 2026 5:39 PM ET
Data refreshes hourly during market hours. Next update: 6:39 PM
Data refreshes hourly during market hours. Next update: 6:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DCTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced DCTH Option Strategies
Professional options setups generated by AI based on today's DCTH price and gamma walls.
